Clinical Trial

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor

Name: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor — clinical trial record (NCT04906434)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is an open-label phase 1 study with an escalation part and an expansion part.

Protocol Amendment History 7 amendments

This ClinicalTrials.gov record has been amended 7 times since 2021-05-25; most recent amendment 2026-04-01.

Trial Details

NCT Number	NCT04906434
Lead Sponsor	Abbisko Therapeutics Co, Ltd
Conditions	Advanced Liver Cancer
Enrollment	200 participants
Start Date	2020-02-26
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-07